A Protocol to Develop T Helper and Treg Cells in Vivo
Weiqian Chen,Zhenjian Xu,Yongjiang Zheng,Julie Wang,Wenbin Qian,Nancy Olsen,David Brand,Jin Lin,Song Guo Zheng
DOI: https://doi.org/10.1038/cmi.2017.116
2017-01-01
Abstract:An understanding of the development and function of T helper (Th) 1, Th17 and regulatory T (Treg) cells is critical toward revealing pro-inflammatory immune responses, especially in autoimmune diseases. However, there is no standard protocol to monitor the development of these cells over time in vivo. This protocol details a method to generate Th1, Th17, and Treg cells in a T cell-induced colitis model in vivo and monitor their dynamic changes, which can be used for further investigations in their development from naive CD4+ T cells in specific gene knockouts and background strains. This protocol starts with the isolation of naive CD4+CD45RBhigh T cells from C57BL/6 IL-17Agfp mice followed by their i.p. injection into recombinase, activating gene-1-deficient (Rag1−/−) mice. At the indicated time points, mice are killed, and mesenteric lymphocytes and murine lamina propria mononuclear cells are isolated and subjected to flow cytometric analysis to assess the development of Th1, Th17, and Treg cells and Th2, Th9, Th22, and follicular T helper (Tfh) cells. This protocol can be completed within 8 weeks.